Review on Pharmaceutical Industries Production of Medicines for Lung Cancer Diseases Prevention and Side Effects DataSets View and Analysis with Orange Software Visualization Techniques
International Journal of Management Technology and Social Sciences,
Год журнала:
2025,
Номер
unknown, С. 17 - 44
Опубликована: Янв. 30, 2025
Purpose:
The
purpose
of
this
research
is
to
explore
how
Orange,
a
powerful
information
extraction
and
predictive
modeling
software,
can
be
applied
in
the
pharmaceutical
industry
assess
visualize
effectiveness
cancer
prevention
medicines.
By
focusing
on
companies
like
Genentech
Inc.
(USA),
AstraZeneca
Pharmaceutical
PLC
(UK),
Boehringer
Ingelheim
(Germany),
Chugai
Co.
Ltd.
(Japan),
study
seeks
evaluate
which
cancer-preventing
drugs
from
these
provide
best
efficacy
while
minimizing
side
effects
for
patients.
goal
assist
healthcare
professionals
(doctors
pharmacists)
making
informed
decisions
about
most
suitable
medications
prevention,
ensuring
patient
safety
optimal
treatment
outcomes.
Design/Methodology/Approach:
This
utilizes
Orange
software’s
machine
learning
data
visualization
tools,
specifically
scatterplot
graphs,
analyze
complex
datasets
related
drugs.
using
scatterplots
concurrently
examine
multiple
parameters,
such
as
Company
Name,
Drug
Class,
Medicine
Prevention
Cancer
Diseases,
Side
Effects
Percentage
aims
identify
patterns
correlations
that
help
drug
safety.
approach
involves
analyzing
relationship
between
characteristics
effects,
providing
actionable
insights
into
different
treatments
might
interact
with
health
conditions.
Findings/Results:
findings
suggest
Orange’s
visualizations
valuable
various
medicines
across
companies.
enabling
simultaneous
analysis
software
helps
are
effective
preventing
effects.
provides
clearer
understanding
characteristics,
outcomes,
supporting
data-driven
decision-making
development
practices.
Originality/Value:
originality
lies
application
mining
capabilities
relationships
within
datasets.
use
efficacy,
an
innovative
offers
richer,
more
nuanced
contributes
optimizing
choice
strategies,
ultimately
improving
therapeutic
Paper
Type:
analytical
paper
applies
techniques
focuses
tools
extract
interpret
data,
professionals.
Язык: Английский
Comprehensive analysis of a palmitoylation‑related prognostic signature in colorectal cancer: Implications for immune therapy and personalized treatment
Oncology Letters,
Год журнала:
2025,
Номер
30(1), С. 1 - 15
Опубликована: Май 16, 2025
Colorectal
cancer
(CRC)
remains
one
of
the
leading
causes
cancer-associated
mortality
worldwide.
While
immune
checkpoint
inhibitors
have
shown
promise
in
treatment,
there
is
a
need
for
reliable
biomarkers
to
predict
patient
prognosis
and
guide
personalized
therapies.
Palmitoylation,
post-translational
modification,
has
been
implicated
various
processes,
yet
its
role
CRC
unclear.
Transcriptome,
survival,
somatic
mutation
copy
number
variation
data
were
retrieved
from
The
Cancer
Genome
Atlas,
GSE17538
dataset
was
used
external
validation.
A
palmitoylation-related
risk
signature
developed
using
univariate
Cox
regression,
Least
Absolute
Shrinkage
Selection
Operator
multivariate
regression
analyses.
Patients
stratified
into
high-
low-risk
groups
based
on
median
score.
Prognostic
accuracy
assessed
receiver
operating
characteristic
curves
Kaplan-Meier
overall
survival
(OS)
analysis
with
validation
an
independent
cohort.
Functional
enrichment,
cell
infiltration
drug
sensitivity
analyses
performed
explore
underlying
mechanisms
therapeutic
implications.
Subsequently,
keratin
8
pseudogene
12
(KRT8P12)
overexpression
evaluated
HT29
cells,
knockdown
lines
generated
lentivirus.
Cell
proliferation
Counting
Kit-8
5-ethynyl-2'-deoxyuridine
assays,
migration
by
Transwell
assay
apoptosis
Annexin-V/propidium
iodide
staining.
consisting
six
genes
(KRT8P12,
ZDHHC3,
PCOLCE2,
MPP2,
LARS2
MMAA)
identified.
High-risk
patients
exhibited
significantly
worse
OS
(HR=3.19;
P<0.001)
compared
patients.
Immune
revealed
enhanced
activity
group,
which
associated
higher
expression
genes.
Immunotherapy
prediction
models
indicated
that
might
benefit
more
inhibitors.
Drug
identified
distinct
response
profiles
between
groups.
Furthermore,
vitro,
KRT8P12
promoted
tumor
while
inhibiting
apoptosis.
In
conclusion,
present
study
confirmed
as
gene
regulating
CRC.
addition,
palmitoylation-associated
may
offer
promising
tool
prognostic
could
treatment
strategies,
including
targeted
Язык: Английский